DK3511422T3 - Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose - Google Patents
Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose Download PDFInfo
- Publication number
- DK3511422T3 DK3511422T3 DK18198701.7T DK18198701T DK3511422T3 DK 3511422 T3 DK3511422 T3 DK 3511422T3 DK 18198701 T DK18198701 T DK 18198701T DK 3511422 T3 DK3511422 T3 DK 3511422T3
- Authority
- DK
- Denmark
- Prior art keywords
- endometriosis
- prognosis
- diagnosing
- compositions
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361903286P | 2013-11-12 | 2013-11-12 | |
EP14192587.5A EP2891722B1 (en) | 2013-11-12 | 2014-11-10 | Methods and compositions for diagnosing, prognosing, and treating endometriosis |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3511422T3 true DK3511422T3 (da) | 2023-02-06 |
Family
ID=51870909
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14192587.5T DK2891722T3 (da) | 2013-11-12 | 2014-11-10 | Fremgangsmåder og sammensætninger til diagnosticering af, prognose for og behandling af endometriose |
DK18198701.7T DK3511422T3 (da) | 2013-11-12 | 2014-11-10 | Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK14192587.5T DK2891722T3 (da) | 2013-11-12 | 2014-11-10 | Fremgangsmåder og sammensætninger til diagnosticering af, prognose for og behandling af endometriose |
Country Status (4)
Country | Link |
---|---|
US (3) | US10174376B2 (da) |
EP (2) | EP3511422B1 (da) |
DK (2) | DK2891722T3 (da) |
FI (1) | FI3511422T3 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
WO2018152487A1 (en) * | 2017-02-20 | 2018-08-23 | University Of Southern California | Compositions and methods for predicting analytic success of t-cell quantification and t-cell receptor sequencing |
CN107391962B (zh) * | 2017-09-05 | 2020-12-29 | 武汉古奥基因科技有限公司 | 基于多组学分析基因或位点对疾病调控关系的方法 |
CN109929915A (zh) * | 2017-12-15 | 2019-06-25 | 安徽普元生物科技股份有限公司 | 甲状腺激素受体(TSHR)mRNA核酸定量检测试剂盒(PCR-荧光探针法) |
EP4177356A1 (en) | 2018-08-08 | 2023-05-10 | PML Screening, LLC | Methods for assessing risk of developing a viral disease using a genetic test |
WO2021072387A1 (en) * | 2019-10-10 | 2021-04-15 | Juneau Biosciences, L.L.C. | Methods of using genetic markers associated with endometriosis |
AU2020372405A1 (en) * | 2019-10-22 | 2022-05-26 | Aim Immunotech Inc. | Methods and compositions for treating endometriosis |
CN116144708A (zh) * | 2022-09-29 | 2023-05-23 | 西南大学 | 一种全雄不育尼罗罗非鱼品系及其构建方法 |
Family Cites Families (71)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4557501A (en) | 1984-07-24 | 1985-12-10 | Farleigh James R | Method and apparatus for improving directional stability of motor vehicles |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
GB8810400D0 (en) | 1988-05-03 | 1988-06-08 | Southern E | Analysing polynucleotide sequences |
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
DE768377T1 (de) | 1988-09-02 | 1998-01-02 | Dyax Corp | Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5424186A (en) | 1989-06-07 | 1995-06-13 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis |
US5527681A (en) | 1989-06-07 | 1996-06-18 | Affymax Technologies N.V. | Immobilized molecular synthesis of systematically substituted compounds |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
DK0585287T3 (da) | 1990-07-10 | 2000-04-17 | Cambridge Antibody Tech | Fremgangsmåde til fremstilling af specifikke bindingsparelementer |
ES2113940T3 (es) | 1990-12-03 | 1998-05-16 | Genentech Inc | Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas. |
EP0562025B1 (en) | 1990-12-06 | 2001-02-07 | Affymetrix, Inc. (a Delaware Corporation) | Compounds and their use in a binary synthesis strategy |
DE69233697T2 (de) | 1991-03-01 | 2008-01-24 | Dyax Corp., Cambridge | Verfahren zur Entwicklung von bindenden Mikroproteinen |
DE69233750D1 (de) | 1991-04-10 | 2009-01-02 | Scripps Research Inst | Bibliotheken heterodimerer Rezeptoren mittels Phagemiden |
DE4122599C2 (de) | 1991-07-08 | 1993-11-11 | Deutsches Krebsforsch | Phagemid zum Screenen von Antikörpern |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
ATE205542T1 (de) | 1992-03-04 | 2001-09-15 | Univ California | Vergleichende genomhybridisierung |
US5541061A (en) | 1992-04-29 | 1996-07-30 | Affymax Technologies N.V. | Methods for screening factorial chemical libraries |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
US5858659A (en) | 1995-11-29 | 1999-01-12 | Affymetrix, Inc. | Polymorphism detection |
JPH09507121A (ja) | 1993-10-26 | 1997-07-22 | アフィマックス テクノロジーズ ナームロゼ ベノートスハップ | 生物学的チップ上の核酸プローブアレー |
DE69527585T2 (de) | 1994-06-08 | 2003-04-03 | Affymetrix Inc | Verfahren und Vorrichtung zum Verpacken von Chips |
US6287850B1 (en) | 1995-06-07 | 2001-09-11 | Affymetrix, Inc. | Bioarray chip reaction apparatus and its manufacture |
US6300063B1 (en) | 1995-11-29 | 2001-10-09 | Affymetrix, Inc. | Polymorphism detection |
EP1736554B1 (en) | 1996-05-29 | 2013-10-09 | Cornell Research Foundation, Inc. | Detection of nucleic acid sequence differences using coupled ligase detection and polymerase chain reactions |
WO1998020019A1 (en) | 1996-11-06 | 1998-05-14 | Sequenom, Inc. | Compositions and methods for immobilizing nucleic acids to solid supports |
EP0878552A1 (en) | 1997-05-13 | 1998-11-18 | Erasmus Universiteit Rotterdam | Molecular detection of chromosome aberrations |
US6207392B1 (en) | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
US6429027B1 (en) | 1998-12-28 | 2002-08-06 | Illumina, Inc. | Composite arrays utilizing microspheres |
US20030215821A1 (en) | 1999-04-20 | 2003-11-20 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
US7244559B2 (en) | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7211390B2 (en) | 1999-09-16 | 2007-05-01 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7030231B1 (en) | 1999-09-30 | 2006-04-18 | Catalyst Biosciences, Inc. | Membrane type serine protease 1 (MT-SP1) and uses thereof |
US6828097B1 (en) | 2000-05-16 | 2004-12-07 | The Childrens Mercy Hospital | Single copy genomic hybridization probes and method of generating same |
ATE380883T1 (de) | 2000-10-24 | 2007-12-15 | Univ Leland Stanford Junior | Direkte multiplex charakterisierung von genomischer dna |
US20040018491A1 (en) | 2000-10-26 | 2004-01-29 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
AU785425B2 (en) | 2001-03-30 | 2007-05-17 | Genetic Technologies Limited | Methods of genomic analysis |
WO2003029480A2 (en) | 2001-08-31 | 2003-04-10 | The Government Of The United States Of America, Asrepresented By The Secretary Of The Department Of Health And Human Services | Measurements of multiple molecules using a cryoarray |
US6977148B2 (en) | 2001-10-15 | 2005-12-20 | Qiagen Gmbh | Multiple displacement amplification |
US20050124022A1 (en) | 2001-10-30 | 2005-06-09 | Maithreyan Srinivasan | Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6902921B2 (en) | 2001-10-30 | 2005-06-07 | 454 Corporation | Sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
US6916621B2 (en) | 2002-03-27 | 2005-07-12 | Spectral Genomics, Inc. | Methods for array-based comparitive binding assays |
US7011949B2 (en) | 2002-09-30 | 2006-03-14 | Agilent Technologies, Inc. | Methods and compositions for producing labeled probe nucleic acids for use in array based comparative genomic hybridization applications |
ES2338654T5 (es) | 2003-01-29 | 2017-12-11 | 454 Life Sciences Corporation | Amplificación de ácidos nucleicos en emulsión de perlas |
US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US7910353B2 (en) | 2004-02-13 | 2011-03-22 | Signature Genomic Laboratories | Methods and apparatuses for achieving precision genetic diagnoses |
US20060024711A1 (en) | 2004-07-02 | 2006-02-02 | Helicos Biosciences Corporation | Methods for nucleic acid amplification and sequence determination |
US20060012793A1 (en) | 2004-07-19 | 2006-01-19 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
US7276720B2 (en) | 2004-07-19 | 2007-10-02 | Helicos Biosciences Corporation | Apparatus and methods for analyzing samples |
US20060024678A1 (en) | 2004-07-28 | 2006-02-02 | Helicos Biosciences Corporation | Use of single-stranded nucleic acid binding proteins in sequencing |
AU2005327929A1 (en) * | 2005-02-18 | 2006-08-31 | Ponce School Of Medicine | Identification of molecular diagnostic markers for endometriosis in blood lymphocytes |
EP1889058A4 (en) * | 2005-05-05 | 2008-10-29 | Mount Sinai Hospital Corp | DIAGNOSIS AND TREATMENT OF ENDOMETRIOSIS |
EP3620469A1 (en) | 2006-02-28 | 2020-03-11 | Biogen MA Inc. | Methods of treating inflammatory and autoimmune diseases with natalizumab |
US7702468B2 (en) | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
US20080305967A1 (en) * | 2007-06-11 | 2008-12-11 | Juneau Biosciences, Llc | Genetic Markers Associated with Endometriosis and Use Thereof |
US8932993B1 (en) | 2007-06-11 | 2015-01-13 | Juneau Biosciences, LLC. | Method of testing for endometriosis and treatment therefor |
US11287425B2 (en) * | 2009-04-22 | 2022-03-29 | Juneau Biosciences, Llc | Genetic markers associated with endometriosis and use thereof |
EP2200611A4 (en) | 2007-09-14 | 2010-09-22 | Biogen Idec Inc | COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE MULTIFOCAL LEUCOENCEPHALEPATHY (PML) |
WO2012018387A2 (en) | 2010-08-02 | 2012-02-09 | Population Diagnotics, Inc. | Compositions and methods for discovery of causative mutations in genetic disorders |
CN103436606B (zh) | 2013-08-01 | 2014-10-29 | 中山大学附属肿瘤医院 | 一种用于食管癌辅助诊断和/或预后判断的试剂盒 |
EP3757224A3 (en) | 2014-02-27 | 2021-03-17 | Biogen MA Inc. | Method of assessing risk of pml |
US9909167B2 (en) | 2014-06-23 | 2018-03-06 | The Board Of Trustees Of The Leland Stanford Junior University | On-slide staining by primer extension |
JP2016031772A (ja) | 2014-07-30 | 2016-03-07 | 株式会社日立ハイテクファインシステムズ | 熱アシスト磁気ヘッド素子の検査方法及びその装置 |
US20170035703A1 (en) | 2015-10-29 | 2017-02-09 | Hans M. Albertsen | Method of Treating Adhesion by Altering an Epithelial to Mesenchymal Transition |
-
2014
- 2014-11-10 DK DK14192587.5T patent/DK2891722T3/da active
- 2014-11-10 DK DK18198701.7T patent/DK3511422T3/da active
- 2014-11-10 FI FIEP18198701.7T patent/FI3511422T3/fi active
- 2014-11-10 EP EP18198701.7A patent/EP3511422B1/en active Active
- 2014-11-10 EP EP14192587.5A patent/EP2891722B1/en active Active
- 2014-11-11 US US14/538,404 patent/US10174376B2/en active Active
-
2018
- 2018-11-21 US US16/197,593 patent/US11384397B2/en active Active
-
2022
- 2022-05-06 US US17/738,499 patent/US20220380851A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220380851A1 (en) | 2022-12-01 |
US20150132295A1 (en) | 2015-05-14 |
EP3511422B1 (en) | 2022-12-28 |
DK2891722T3 (da) | 2019-01-07 |
EP3511422A2 (en) | 2019-07-17 |
US10174376B2 (en) | 2019-01-08 |
EP2891722B1 (en) | 2018-10-10 |
EP2891722A1 (en) | 2015-07-08 |
US20190249252A1 (en) | 2019-08-15 |
EP3511422A3 (en) | 2019-08-07 |
FI3511422T3 (fi) | 2023-01-31 |
US11384397B2 (en) | 2022-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3556869T3 (da) | Sammensætninger og fremgangsmåder til sekventering af polynukleotider | |
DK3245225T3 (da) | Sammensætninger og fremgangsmåder til behandling og detektering af cancere | |
DK2970456T3 (da) | Fremgangsmåder og sammensætninger til levering af mrna-kodede antistoffer | |
DK3252160T3 (da) | Systemer, fremgangsmåder og sammensætninger med crispr-cas-bestanddele til sekvensmanipulation | |
DK3071215T3 (da) | Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension | |
DK3508502T3 (da) | Kombination af anti-lag-3-antistoffer og anti-pd-1-antistoffer til behandling af tumorer | |
DK3008168T3 (da) | Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf | |
DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
DK2961831T3 (da) | Sammensætninger og fremgangsmåder til immunterapi | |
BR112016011684A2 (pt) | método, e composição de cimento | |
DK3080274T3 (da) | Fremgangsmåder og sammensætninger til genom-manipulation | |
DK3043816T3 (da) | Anti-b7-h1-antistoffer til behandling af tumorer | |
DK2984166T3 (da) | Sammensætninger til behandling af mpsi | |
DK3030323T3 (da) | Kdm1a-inhibitorer til behandlingen af sygdom | |
DK3511422T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering, prognose og behandling af endometriose | |
DK3007695T3 (da) | Sammensætninger og fremgangsmåder til behandling af anæmi | |
DK3204386T3 (da) | Substituerede aminopurinforbindelser, sammensætninger deraf og fremgangsmåder til behandling dermed | |
DK2994533T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
DK3209696T3 (da) | Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom | |
DK3083680T3 (da) | Humaniserede anti-Tau(pS422)-antistoffer og fremgangsmåder til anvendelse | |
DK2967049T3 (da) | Metoder, forbindelser og sammensætninger til behandlingen af angiotensin relaterede sygdomme | |
DK3087184T3 (da) | Fremgangsmåder og sammensætninger til specifik inhibering af glycolatoxidase (hao1) med dobbeltstrenget rna | |
DK3021838T3 (da) | Behandling af fedme | |
DK3200815T3 (da) | Fremgangsmåder og sammensætninger til behandling af cancer | |
DK2830654T3 (da) | Metoder og sammensætninger til behandling af inflammation |